文献速递产科母胎医学

孕中晚期血清GDF-15水平预测子痫前期

Second- and third-trimester serum levels of growth-differentiation factor-15 in prediction of pre-eclampsia.
PubMed 文献 · Ultrasound Obstet Gynecol · 2020-11-09

本研究为病例对照研究,比较无症状孕妇在孕19-24周、30-34周和35-37周血清GDF-15水平,发现仅30-34周时早产型子痫前期患者GDF-15 MoM值显著升高,但差异较小,单独用于临床预测价值有限。

要点

  • 孕19-24周和35-37周GDF-15水平不能预测早产或足月子痫前期。
  • 孕30-34周GDF-15 MoM值在早产型子痫前期中显著升高,但足月型无差异。
  • GDF-15单独用于临床预测子痫前期价值有限。

核心结论

  • 孕19-24周或35-37周血清GDF-15水平不能预测早产或足月子痫前期。
  • 孕30-34周GDF-15水平在后续发生早产型子痫前期的孕妇中较高,但差异小,单独使用不太可能具有临床实用价值。

研究设计与样本

  • 病例对照研究,来源于前瞻性观察研究,纳入常规孕中晚期就诊孕妇。
  • 使用商业GDF-15酶联免疫吸附试验测定300份血清样本:孕19-24周120份、30-34周120份、35-37周60份。
  • 采用多重线性回归分析对数转换后的GDF-15对照值,评估采血孕周和母体特征的影响。
  • 比较经孕周和母体特征调整后的GDF-15中位数倍数(MoM)在后续发生早产或足月子痫前期与健康对照之间的差异。

主要发现

  • GDF-15值随孕周增加而升高。
  • 孕19-24周和35-37周,早产型或足月型子痫前期与血压正常妊娠的GDF-15 MoM值无显著差异。
  • 孕30-34周,早产型子痫前期患者的GDF-15 MoM值显著升高,但后续发生足月型子痫前期者无显著差异。
  • GDF-15 MoM值升高与孕30-34周采血至因子痫前期分娩的间隔缩短显著相关(P = 0.005)。

临床怎么用

  • 孕19-24周和35-37周不推荐单独使用血清GDF-15预测子痫前期。
  • 孕30-34周GDF-15升高与早产型子痫前期相关,但差异小,单独用于临床预测价值有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Pre-eclampsia (PE) is a significant contributor to adverse maternal and perinatal outcome; however, accurate prediction and early diagnosis of this condition remain a challenge. The aim of this study was to compare serum levels of growth-differentiation factor-15 (GDF-15) at three different gestational ages between asymptomatic women who subsequently developed preterm or term PE and healthy controls. METHODS: This was a case-control study drawn from a prospective observational study on adverse pregnancy outcomes in women attending for their routine second- and third-trimester hospital visits. Serum GDF-15 was determined in 300 samples using a commercial GDF-15 enzyme-linked immunosorbent assay: 120 samples at 19-24 weeks of gestation, 120 samples at 30-34 weeks and 60 samples at 35-37 weeks. Multiple linear regression was applied to logarithmically transformed GDF-15 control values to evaluate the influence of gestational age at blood sampling and maternal characteristics on GDF-15 results. GDF-15 multiples of the normal median (MoM) values, adjusted for gestational age and maternal characteristics, were compared between pregnancies that subsequently developed preterm or term PE and healthy controls. RESULTS: Values of GDF-15 increased with gestational age. There were no significant differences in GDF-15 MoM values between cases of preterm or term PE and normotensive pregnancies at 19-24 or 35-37 weeks of gestation. At 30-34 weeks, GDF-15 MoM values were significantly increased in cases of preterm PE, but not in those who later developed term PE. Elevated GDF-15 MoM values were associated significantly with a shorter interval between sampling at 30-34 weeks and delivery with PE (P = 0.005). CONCLUSION: Serum GDF-15 levels at 19-24 or 35-37 weeks of gestation are not predictive of preterm or term PE. At 30-34 weeks, GDF-15 levels are higher in women who subsequently develop preterm PE; however, this difference is small and GDF-15 is unlikely to be useful in clinical practice when used in isolation. Copyright © 2020 ISUOG. Published by John Wiley & Sons Ltd.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Wertaschnigg D, Rolnik DL, Nie G, et al. Second- and third-trimester serum levels of growth-differentiation factor-15 in prediction of pre-eclampsia. Ultrasound Obstet Gynecol. 2020. PMID: 32388891. doi:10.1002/uog.22070

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。